Vanguard News
Behold 8 Nollywood beauties to watch out for in 2021
On
By Juliet Ebirim
Nigeria is home to a vibrant, dazzling and glamourous movie industry. With an array of stars gracing screens and stealing hearts with their talents and looks, Nollywood is definitely a force to reckon with. As 2021 kicks off in earnest, we take a look at fast-rising actresses to watch out for this year.
SHARON OOJA
Sharon Ooja came into limelight after she played the role of “Shalewa” in the web series Skinny Girl in Transit.
The 29-year old Mass Communication graduate gained more popularity in 2018 for her role as ‘Amaka’ in ‘King of Boys’.
Press release content from Business Wire. The AP news staff was not involved in its creation.
TPBank selects Wolters Kluwer’s OneSumX IFRS9
January 28, 2021 GMT
Vietnam’s Tien Phong Commercial
Joint Stock Bank (TPBank) has chosen Wolters Kluwer’s Finance, Risk & Regulatory Reporting (FRR) business to provide software for helping to ensure compliance with International Financial Reporting Standard (IFRS) 9. The bank will use OneSumX IFRS 9, a module of OneSumX for FRR, for managing its obligations around the accounting standard which is set to be implemented in Vietnam in 2023.
ADVERTISEMENT
OneSumX IFRS 9 offers a solid framework combining lifecycle information on each individual financial instrument with a comprehensive set of IFRS 9 calculators. The resulting numbers are recorded in a transparent, traceable, and auditable contract level IFRS subledger. The solution supports regulatory disclosures from local supervisors across the globe and offers powerful reporting too
Evotec AG: Evotec Starts Clinical Development of Chikungunya Antibody together with NIAID and Leading Academic Research Organisation
DEVELOPMENT OF EVT894 BY EVOTEC TOGETHER WITH ITS PARTNERS NIAID AND DUKE CLINICAL RESEARCH INSTITUTE
ADDRESSING UNMET MEDICAL NEEDS IN GLOBAL HEALTH
HAMBURG, GERMANY / ACCESSWIRE / January 28, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that EVT894, a monoclonal antibody to treat and potentially prevent chikungunya virus infections, has entered clinical development.
The Phase I, randomised, double-blind, single centre, single dose escalation study to evaluate the safety, pharmacokinetics, and immunogenicity of EVT894 vs placebo in healthy volunteers (five dose-cohorts of 8 subjects) is sponsored and funded by the National Institute of Allergy and Infectious Diseases ( NIAID ), part of the National Institutes of Health with funds from a Phase I Clinical Trial Units for Therapeutics programme awar
Consolidated net sales for the year increased 2.6% to a record $18.36 billion and increased 9.1% in the quarter to a record $4.49 billion
Net sales from stores in U.S. and Canada open more than twelve calendar months increased 2.7% in the year and 9.3% in the quarter
Full year diluted net income per share increased 33.9% to $22.08 per share compared to $16.49 per share in full year 2019
Excluding the impact of acquisition-related amortization expense, diluted net income per share increased 16.4% to $24.58 per share in the full year versus $21.12 per share in full year 2019, excluding the impact of acquisition-related costs and other adjustments
Full year net operating cash increased
Wolters Kluwer s GRC Division Wins Best Place to Work and Leadership Accolades
Wolters Kluwer s Governance, Risk Compliance (GRC) division has won four major accolades, recognizing it as a Great Place to Work. The awards, all decided by independent editorial panels, celebrate Wolters Kluwer GRC as a global employer that values its staff, recognizes and promotes talent from within and fosters a collaborative and high-performing culture. Wolters Kluwer GRC, which has introduced a number of innovations to help legal and banking professionals respond to the Covid-19 pandemic, has also won two leadership awards, recognizing the work of Wolters Kluwer GRC CEO, Richard Flynn, in leading the division.